Intrinsic Value of S&P & Nasdaq Contact Us

iCAD, Inc. ICAD NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ICAD

iCAD, Inc. (ICAD) has a market capitalization of $106.31M and trades at $3.87. The 52-week range is 1.19-4.01.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18.4, Earnings Per Share (EPS) of $-0.21, annual revenue of $19.61M.

The stock has a beta of 1.40, operates in the Healthcare sector.

Trading Data
Current Price$3.87
52-Week Range1.19-4.01
Volume190.13K
Avg Volume (30D)789.06K
Market Cap$106.31M
Beta (1Y)1.40
Company
IPO Date1984-12-13
Employees66
CEODana R. Brown
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS44934S2068
CUSIP44934S206
Income (Latest Year)
Revenue$19.61M
Gross Profit$16.64M
EBITDA$-4.88M
Operating Income$-6.27M
Net Income$-5.62M
EPS$-0.21
EPS Diluted$-0.21
Shares Outstanding$26.35M
Balance Sheet (Latest Year)
Total Assets$37.54M
Current Assets$26.43M
Cash & ST Investments$17.21M
Total Liabilities$8.86M
Total Debt$362K
Net Debt$-16.84M
Total Equity$28.68M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-18.4
P/S Ratio5.42
P/B Ratio3.71
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message